TissGeneSummary for MT1G |
Gene summary |
Basic gene information | Gene symbol | MT1G |
Gene name | metallothionein 1G | |
Synonyms | MT1|MT1K | |
Cytomap | UCSC genome browser: 16q13 | |
Type of gene | protein-coding | |
RefGenes | NM_001301267.1, NM_005950.2, | |
Description | MT-1GMT-1KMT-IGmetallothionein 1Kmetallothionein-1Gmetallothionein-1Kmetallothionein-IG | |
Modification date | 20141207 | |
dbXrefs | MIM : 156353 | |
HGNC : HGNC | ||
Ensembl : ENSG00000125144 | ||
HPRD : 11827 | ||
Vega : OTTHUMG00000133275 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_MT1G | |
BioGPS: 4495 | ||
Pathway | NCI Pathway Interaction Database: MT1G | |
KEGG: MT1G | ||
REACTOME: MT1G | ||
Pathway Commons: MT1G | ||
Context | iHOP: MT1G | |
ligand binding site mutation search in PubMed: MT1G | ||
UCL Cancer Institute: MT1G | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Liver | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LIHC | |
Reference showing the relevant tissue of MT1G | ||
Description by TissGene annotations | Cancer gene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0045926 | negative regulation of growth | 18332874 | GO:0071294 | cellular response to zinc ion | 7559655 | GO:0045926 | negative regulation of growth | 18332874 | GO:0071294 | cellular response to zinc ion | 7559655 |
Top |
TissGeneExp for MT1G |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KIRP | -2.240365074 | 5.507006801 | -7.747371875 | 1.00E-21 | 7.73E-20 |
LIHC | 0.495627926 | 7.639159926 | -7.143532 | 9.01E-22 | 6.90E-20 |
KIRC | -0.67155813 | 4.502876593 | -5.174434722 | 8.03E-21 | 6.82E-20 |
THCA | 1.475523485 | 5.647020095 | -4.17149661 | 5.16E-12 | 4.08E-11 |
KICH | -2.685706074 | 4.754065926 | -7.439772 | 1.35E-15 | 3.10E-14 |
COAD | 1.316502234 | 4.853263772 | -3.536761538 | 1.12E-09 | 1.24E-08 |
ESCA | 0.500882653 | 4.039982653 | -3.5391 | 0.00361 | 0.032373548 |
HNSC | -1.22695519 | -0.213594725 | -1.013360465 | 0.00325 | 0.0093991 |
Top |
TissGene-miRNA for MT1G |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for MT1G |
TissGeneSNV for MT1G |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.V39L | CESC | 2 |
p.E23K | CESC | 2 |
p.K56R | KIRC | 1 |
p.S17G | CESC | 1 |
p.A9T | ESCA | 1 |
p.A16S | LUAD | 1 |
p.A16T | STAD | 1 |
p.S54L | STAD | 1 |
p.A42V | THYM | 1 |
p.K22R | THYM | 1 |
Top |
TissGeneCNV for MT1G |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for MT1G |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | X13227 | MT1G-DAO | chr16:56701975 | chr12:109273885 | |
Chimerdb3.0 | FusionScan | UCEC | TCGA-BK-A4ZD-01A | MT1G-MT3 | In-Frame | chr16:56701877 | chr16:56624751 |
Top |
TissGeneNet for MT1G |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for MT1G |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for MT1G |
TissGeneDrug for MT1G |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for MT1G |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C2239176 | Liver carcinoma | 6 | BeFree |
umls:C0007134 | Renal Cell Carcinoma | 4 | BeFree,LHGDN |
umls:C0339573 | Glaucoma, Primary Open Angle | 4 | BeFree |
umls:C0376358 | Malignant neoplasm of prostate | 4 | BeFree |
umls:C0596263 | Carcinogenesis | 4 | BeFree |
umls:C0600139 | Prostate carcinoma | 4 | BeFree |
umls:C0238463 | Papillary thyroid carcinoma | 3 | BeFree |
umls:C0027627 | Neoplasm Metastasis | 2 | BeFree |
umls:C0206624 | Hepatoblastoma | 2 | BeFree |
umls:C0242379 | Malignant neoplasm of lung | 2 | BeFree |
umls:C0684249 | Carcinoma of lung | 2 | BeFree |
umls:C1458155 | Mammary Neoplasms | 2 | BeFree |
umls:C0007115 | Malignant neoplasm of thyroid | 1 | BeFree |
umls:C0007131 | Non-Small Cell Lung Carcinoma | 1 | BeFree |
umls:C0009375 | Colonic Neoplasms | 1 | BeFree |
umls:C0009402 | Colorectal Carcinoma | 1 | BeFree |
umls:C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | BeFree |
umls:C0014859 | Esophageal Neoplasms | 1 | CTD_human |
umls:C0022336 | Creutzfeldt-Jakob disease | 1 | BeFree |
umls:C0023467 | Leukemia, Myelocytic, Acute | 1 | BeFree |
umls:C0023487 | Acute Promyelocytic Leukemia | 1 | BeFree |
umls:C0029456 | Osteoporosis | 1 | BeFree |
umls:C0040136 | Thyroid Neoplasm | 1 | LHGDN |
umls:C0410702 | Adolescent idiopathic scoliosis | 1 | BeFree |
umls:C0549473 | Thyroid carcinoma | 1 | BeFree |
umls:C0686619 | Secondary malignant neoplasm of lymph node | 1 | BeFree |
umls:C1527249 | Colorectal Cancer | 1 | BeFree |
umls:C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1 | BeFree |
umls:C3714542 | Lymphoma, Diffuse | 1 | BeFree |